Eplerenone good for heart failure

inspra

No surprises here – the eplerenone trial in heart failure, EMPHASIS-HF, has been stopped early because of the benefit of eplerenone over placebo in heart failure. The study, run by Pfizer, looked at over 3,000 patients with mild heart failure (NYHA II).
EPHESUS has already shown us that eplerenone is useful for hypertension and for congestive heart failure post MI – perhaps these results will extend its usefulness to mild heart failure. 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s